All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
More information on our cookie policy.
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Special reports
Artificial intelligence
Coronavirus
Diagnosing and tracking COVID-19
Drugs to Watch 2020
The next pandemic
Premium reports
BioWorld Financings Reports
Disease Forecast Reports
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, March 1, 2021
See today's BioWorld
Home
» Opting for Nasdaq, I-Mab files for $100M IPO in U.S.
To read the full story,
subscribe
or
sign in
.
Opting for Nasdaq, I-Mab files for $100M IPO in U.S.
Oct. 31, 2019
By
David Ho
No Comments
HO
NG KONG – Shanghai-based
I-Mab Biopharma Co. Ltd.
has filed for an IPO in the U.S., seeking to raise up to $100 million.
BioWorld
Financings
